A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine

OBJECTIVE: This study aimed to investigate the breakthrough infection rate and safety profile of the AstraZeneca vaccine. METHODS: The breakthrough COVID-19 infection rate was defined as a positive polymerase chain reaction test 14 days after the vaccine dose. Safety was assessed as local reactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Nawfal R., Rasheed, Bizav Naji, Naqid, Ibrahim A., Dirbaz, Arshed Mustafa, Saleem, Zana Sidiq M., Ibrahim, Nashwan, Musa, Dildar H., Mohammed, Sulav Muslih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339090/
https://www.ncbi.nlm.nih.gov/pubmed/35936975
http://dx.doi.org/10.1016/j.puhip.2022.100303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339090/
https://www.ncbi.nlm.nih.gov/pubmed/35936975
http://dx.doi.org/10.1016/j.puhip.2022.100303

Ejemplares similares